Annual report pursuant to Section 13 and 15(d)

Consolidated Statements Of Stockholders' Equity (Unaudited)

v3.20.1
Consolidated Statements Of Stockholders' Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Other Comprehensive Income / Loss
Treasury Stock
Total
Beginning balance, shares at Dec. 31, 2017 3,090,742 753,659          
Beginning balance, value at Dec. 31, 2017 $ 3,090 $ 754 $ 165,258,198 $ (145,933,137) $ 253,734 $ (5,281,180) $ 14,301,459
Exercise of warrants, shares   30,834          
Exercise of warrants, value   $ 31 1,479,969       1,480,000
Conversion of Series B preferred stock to shares of common stock, shares (316,348) 26,363          
Conversion of Series B preferred stock to shares of common stock, value $ (316) $ 26 290        
Issuance of common stock to vendor, value     69,708       69,708
Share-based expense     1,362,079       1,362,079
Net loss       (7,300,458)     (7,300,458)
Ending balance, shares at Dec. 31, 2018 2,774,394 810,856          
Ending balance, value at Dec. 31, 2018 $ 2,774 $ 811 168,170,244 (153,233,595) 253,734 (5,281,180) 9,912,788
Common stock and warrants issued new, shares   1,833,333          
Common stock and warrants issued new, value   $ 1,834 16,119,166       16,121,000
Issuance of common stock in connection with purchase of in-process research and development, shares   624,995          
Issuance of common stock in connection with purchase of in-process research and development, value   $ 625 3,030,601       3,031,226
Exercise of pre-funded warrants, shares   612,417          
Exercise of pre-funded warrant, value   $ 612 5,597       6,209
Exercise of purchase warrants, shares   2,201,553          
Exercise of purchase warrants, value   $ 2,202 (2,202)        
Issuance of common stock to vendor, shares   7,836          
Issuance of common stock to vendor, value   $ 7 (7)        
Issuance of warrants in connection with reverse stock split, value     63,536       63,536
Issuance of common stock to adjust for reverse split rounding, shares   1,442          
Issuance of common stock to adjust for reverse split rounding, value   $ 1 (1)        
Deemed dividend related to Series B Preferred Stock down round provision     5,284,379       5,284,379
Accretion of deemed dividend related to Series B Preferred Stock down round provision     (5,284,379)       (5,284,379)
Share-based expense     806,090       806,090
Common stock awards to vendors     47,427       47,427
Net loss       (12,775,025)     (12,775,025)
Ending balance, shares at Dec. 31, 2019 2,774,394 6,092,432          
Ending balance, value at Dec. 31, 2019 $ 2,774 $ 6,092 $ 188,240,451 $ (166,008,620) $ 253,734 $ (5,281,180) $ 17,213,251